Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 24803676

Phase II study of sorafenib in children with recurrent or progressive low-grade astrocytomas.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Neuro Oncol
Publication date
2014 Oct
First author
Karajannis MA

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Karajannis MA
      type
      Author
    2. name
      Legault G
      type
      Author
    3. name
      Fisher MJ
      type
      Author
    4. name
      Milla SS
      type
      Author
    5. name
      Cohen KJ
      type
      Author
    6. name
      Wisoff JH
      type
      Author
    7. name
      Harter DH
      type
      Author
    8. name
      Goldberg JD
      type
      Author
    9. name
      Hochman T
      type
      Author
    10. name
      Merkelson A
      type
      Author
    11. name
      Bloom MC
      type
      Author
    12. name
      Sievert AJ
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Karajannis MA
      type
      Author
    2. name
      Legault G
      type
      Author
    3. name
      Fisher MJ
      type
      Author
    4. name
      Milla SS
      type
      Author
    5. name
      Cohen KJ
      type
      Author
    6. name
      Wisoff JH
      type
      Author
    7. name
      Harter DH
      type
      Author
    8. name
      Goldberg JD
      type
      Author
    9. name
      Hochman T
      type
      Author
    10. name
      Merkelson A
      type
      Author
    11. name
      Bloom MC
      type
      Author
    12. name
      Sievert AJ
      type
      Author
    bibliography ids
    1. nci-bib-81764ad2ba1316a7a0f94935
    book metadata
    content sha256
    40b1cf31b46138552493d78902b27f70e73ca2909b74aa56e001cd9af6999099
    document type
    citation
    dois
    1. 10.1093/neuonc/nou059
    electronic publication date
    display
    2014 May 6
    precision
    day
    year
    2014
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:24803676
    immutable id
    pubmed:24803676@40b1cf31b46138552493d78902b27f70e73ca2909b74aa56e001cd9af6999099
    journal
    abbreviation
    Neuro Oncol
    issn electronic
    1523-5866
    issn print
    1522-8517
    issue
    10
    name
    Neuro-oncology
    nlm unique id
    100887420
    pages
    1408-16
    volume
    16
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      24803676
      provenance
      batch id
      063b6c38419f18d4021f
      provider
      NCBI PubMed ESummary
      record sha256
      737995568724d679a5a482b6e18791eeec97c66cb83474a6ce2b20cb2fc9bde5
      response sha256
      5abcae41e9384a85f92695ef76b244ffd933f07a58a51082c160af8743d196ad
      retrieved at
      2026-09-09T23:47:02.607425+00:00
      publication date
      display
      2014 Oct
      precision
      month
      year
      2014
      publication types
      1. Clinical Trial, Phase II
      2. Journal Article
      3. Multicenter Study
      4. Research Support, N.I.H., Extramural
      5. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/24803676/
      title
      Phase II study of sorafenib in children with recurrent or progressive low-grade astrocytomas.

      Preserved source evidence · Not medical advice